- Home
- COLL vs SPB Comparison
COLL vs SPB Comparison
Compare COLL & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COLL | SPB |
|---|---|---|
| Founded | 2002 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | COLL | SPB |
|---|---|---|
| Price | $47.02 | $58.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $47.50 | ★ $83.50 |
| AVG Volume (30 Days) | ★ 550.1K | 358.1K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 3.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.63 | ★ 3.86 |
| Revenue | $757,067,000.00 | ★ $2,809,000,000.00 |
| Revenue This Year | $26.35 | $1.64 |
| Revenue Next Year | $3.67 | $1.47 |
| P/E Ratio | $29.21 | ★ $15.11 |
| Revenue Growth | ★ 26.34 | N/A |
| 52 Week Low | $23.23 | $49.99 |
| 52 Week High | $49.09 | $96.62 |
Technical Indicators
Market Signals| Indicator | COLL | SPB |
|---|---|---|
| Relative Strength Index (RSI) | 68.88 | 56.37 |
| Support Level | $46.81 | $55.93 |
| Resistance Level | $49.09 | $58.86 |
| Average True Range (ATR) | 1.33 | 1.64 |
| MACD | -0.19 | -0.06 |
| Stochastic Oscillator | 69.59 | 74.96 |
Price Performance
Historical ComparisonAbout COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.